GR1000609B - Μεθοδος παραγωγης πορφυρινων. - Google Patents

Μεθοδος παραγωγης πορφυρινων.

Info

Publication number
GR1000609B
GR1000609B GR890100817A GR890100817A GR1000609B GR 1000609 B GR1000609 B GR 1000609B GR 890100817 A GR890100817 A GR 890100817A GR 890100817 A GR890100817 A GR 890100817A GR 1000609 B GR1000609 B GR 1000609B
Authority
GR
Greece
Prior art keywords
cells
protoporphyrin
profyrina
production method
disclosed
Prior art date
Application number
GR890100817A
Other languages
English (en)
Other versions
GR890100817A (en
Inventor
Phillip Halling Blaik
Debra Ann Witkowski
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of GR890100817A publication Critical patent/GR890100817A/el
Publication of GR1000609B publication Critical patent/GR1000609B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Κοινολογείται μια μέθοδος και μια φαρμακευτική σύνθεση για την εξόντωση κυττάρων όγκου θηλαστικών με υποβολή των αναφερμένων κυττάρων σε φως σε παρουσία ενός ενεργοποιήσιμου στο φως τετραπυρρόλιου----, όπου η βελτίωση περιλαμβάνει αγωγή των αναφερμένων κυττάρων με μια ένωση που αναστέλλει την ενζυματική μετατροπή του πρωτοπορφυρινογόνου σε πρωτοπορφυρίνη ΙΧ με οξειδάση πρωτοπορφυρινογόνου στα αναφερμένα κύτταρα με τον τρόπο αυτό προκαλώντας μια ενίσχυση της πρωτοπορφυρίνης ΙΧ στα αναφερμένα κύτταρα. Κοινολογείται επίσης μια μέθοδος για την παραγωγή πρωτοπορφυρίνης ΙΧ που περιλαμβάνει ανάπτυξη ευκαρυωτικών μικροαλγών σε παρουσία ενός αναστολέα οξείδασης πρωτοπορφυρινογόνου. ω
GR890100817A 1988-12-12 1989-12-12 Μεθοδος παραγωγης πορφυρινων. GR1000609B (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03

Publications (2)

Publication Number Publication Date
GR890100817A GR890100817A (en) 1991-03-15
GR1000609B true GR1000609B (el) 1992-08-31

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100817A GR1000609B (el) 1988-12-12 1989-12-12 Μεθοδος παραγωγης πορφυρινων.

Country Status (28)

Country Link
EP (1) EP0447491B1 (el)
JP (1) JP2545000B2 (el)
KR (1) KR930003116B1 (el)
AR (1) AR243605A1 (el)
AT (1) AT400520B (el)
AU (1) AU633537B2 (el)
BR (1) BR8907817A (el)
CA (1) CA2004979A1 (el)
CH (1) CH681779A5 (el)
DE (2) DE3991484T (el)
DK (1) DK110791A (el)
EG (1) EG18822A (el)
ES (1) ES2051675T3 (el)
FI (1) FI912784A0 (el)
GB (1) GB2247404B (el)
GR (1) GR1000609B (el)
HU (1) HUT58202A (el)
IE (1) IE62621B1 (el)
IL (1) IL92622A (el)
LU (1) LU87949A1 (el)
LV (1) LV10303B (el)
MC (1) MC2171A1 (el)
NO (1) NO912228D0 (el)
NZ (1) NZ231658A (el)
OA (1) OA09362A (el)
PT (1) PT92546B (el)
SE (1) SE505938C2 (el)
WO (1) WO1990006748A2 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6084155A (en) 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
HUP9901044A3 (en) * 1996-02-28 2001-11-28 Syngenta Participations Ag Dna molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
DK2443102T3 (da) 2009-06-19 2013-07-08 Basf Se Herbicidale benzoxazinoner
EP2496573B1 (en) * 2009-11-02 2015-07-01 Basf Se Herbicidal tetrahydrophthalimides
JP2013540113A (ja) 2010-10-01 2013-10-31 ビーエーエスエフ ソシエタス・ヨーロピア 除草性ベンゾオキサジノン
WO2012080239A1 (en) 2010-12-15 2012-06-21 Basf Se Herbicidal compositions
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
BR112019010732B1 (pt) * 2016-12-16 2023-01-31 Basf Se Feniltriazolinonas, processo para a preparação de feniltriazolinonas, composições herbicidas, processo para a preparação de composições ativas de herbicida, método para controlar vegetação indesejada e uso das feniltriazolinonas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides

Also Published As

Publication number Publication date
GB2247404B (en) 1993-03-03
GB9110472D0 (en) 1991-11-27
ATA903489A (de) 1995-06-15
IL92622A0 (en) 1990-08-31
PT92546B (pt) 1995-09-12
WO1990006748A2 (en) 1990-06-28
EP0447491B1 (en) 1993-08-11
DE3991484C2 (de) 1995-02-23
AU633537B2 (en) 1993-02-04
NO912228L (no) 1991-06-11
WO1990006748A3 (en) 1990-10-04
ES2051675T3 (es) 1994-11-01
JPH04501420A (ja) 1992-03-12
PT92546A (pt) 1990-06-29
IL92622A (en) 1996-05-14
LV10303B (en) 1995-08-20
FI912784A7 (fi) 1991-06-10
DK110791D0 (da) 1991-06-11
AU4822290A (en) 1990-07-10
EG18822A (en) 1994-09-29
KR930003116B1 (ko) 1993-04-19
SE9101807L (sv) 1991-06-12
MC2171A1 (fr) 1992-05-22
AR243605A1 (es) 1993-08-31
NZ231658A (en) 1992-05-26
CA2004979A1 (en) 1990-06-12
IE62621B1 (en) 1995-02-22
KR910700046A (ko) 1991-03-13
JP2545000B2 (ja) 1996-10-16
ES2051675T1 (es) 1994-07-01
GR890100817A (en) 1991-03-15
DE3991484T (el) 1991-11-21
IE893925L (en) 1990-06-12
DK110791A (da) 1991-08-12
BR8907817A (pt) 1991-10-22
FI912784A0 (fi) 1991-06-10
HUT58202A (en) 1992-02-28
SE505938C2 (sv) 1997-10-27
LV10303A (lv) 1994-10-20
SE9101807D0 (sv) 1991-06-12
EP0447491A1 (en) 1991-09-25
GB2247404A (en) 1992-03-04
OA09362A (en) 1992-09-15
NO912228D0 (no) 1991-06-11
AT400520B (de) 1996-01-25
LU87949A1 (fr) 1991-12-16
CH681779A5 (el) 1993-05-28

Similar Documents

Publication Publication Date Title
TR199700574T1 (xx) Molek�ler �aperon �retiminin haz�rlanmas� i�in yararl� hidroksilamin t�revleri ve bu t�revlerin haz�rlanmas�.
SE9101807D0 (sv) Framstaellning och anvaendning av porfyriner
DE3852714D1 (de) Oligodesoxynukleotide als Inhibitoren der Replikation von Retroviren und der Expression von Onkogenen.
ATE114972T1 (de) Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
ES8605377A1 (es) Compuesto farmaceutico apropiado para administracion por via intestinal
ES2056843T3 (es) Amidas de acidos grasos inhibidoras de acil-coa: colesterol aciltransferasa.
RU96102402A (ru) Композиция для фотодинамического повреждения клеток-мишеней и способ фотодинамического повреждения клеток-мишеней
ES2086408T3 (es) Mejora en el blanqueo de una pasta.
EP0175709A4 (en) Substance, composition of matter and method of using same.
NO994330L (no) Metode for behandling av en tumor
ES2053988T3 (es) Un metodo para la produccion de una composicion eficaz para traqueobroncodilatacion.
DK156668C (da) Fremgangsmaade til kvantitativ bestemmelse af blodkoagulationsfaktor xii i humant plasma
TR199903074T2 (xx) Kanser tedavisinde HMG CoA ve farnesil transfer �nleyicileri.
MX9302294A (es) Celula tumoral inmunogenica y metodo para su produccion.
Adelstein et al. The effects of X-irradiation in solution on the kinetic, sedimentation and fluorescent properties of glutamic acid dehydrogenase
ES2039578T3 (es) Procedimiento para producir mercapto-acilaminoacidos antihipertensivos.
DE69417895D1 (de) Direkter cholesterolassay
ES2111526T3 (es) Arilsulfatasa.
ES2026485T3 (es) Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas.
GB8316758D0 (en) Production of anti-viral agents
BG34037A3 (bg) Метод за получаване на субституирани n-метиленови производни на тиенамицина
KR910008138A (ko) 효소법에 의한 l-세린의 제조법
Caputto et al. Light inhibits the labelling of gangliosides in chicken retina
MD861G2 (ro) Procedeu şi compoziţie farmaceutică pentru distrugerea celulelor tumorale ale mamiferelor
ES2039250T3 (es) Tratamiento de materiales de lana.